发明名称 VACCINES
摘要 <p>PURPOSE: Provided is a new vaccine composition comprising alum, an antigen, an immunologically active saponin fraction like as QS21 that induced from cortex of Quillaja Saponaria Molina and a sterol. A manufacturing method thereof, and using method to drug are also provided. CONSTITUTION: A process for the preparation of the vaccine composition comprises of: vacuumed-drying a mixture of lipid and a cholesterol in organic solvent, adding solution(e.g., phosphate buffer saline), and shaking, fluidifying the suspension finely till the liposome size be 100nm, and sterilized-filtering through 0.2micrometer filter to get SUV(small unilamella vesicle); adding an antigen(1-500microgram) to alum in water(100-500microgram), adding water till the volume be 500μl, incubating 15-30minutes, adding MPL(3-deacylated mono-phosphoryl lipid A) 50microgram as a form of an elementary particulated MPL, leaving for 15-30minutes at room temperature, adding 10times concentrated phosphate buffer saline till the last concentration be an equal-osmosis, and incubating; adding QS21 to SUV, and adding the mixture to the alum/antigen/buffer mixture; adding bacteria-growth inhibitor like as thiomersal, if needed.</p>
申请公布号 KR20000048866(A) 申请公布日期 2000.07.25
申请号 KR19997002874 申请日期 1999.04.02
申请人 SMITHKLINE BEECHAM BIOLOGICALS S.A. 发明人 GARCON, NATHALIE;FRIEDE, MARTIN
分类号 A61K39/00;A61K39/015;A61K39/02;A61K39/095;A61K39/10;A61K39/112;A61K39/118;A61K39/125;A61K39/145;A61K39/21;A61K39/245;A61K39/29;A61K39/39;A61P31/04;A61P31/14;A61P31/16;A61P31/18;A61P31/20;A61P31/22;A61P33/02;A61P33/06;A61P35/00;(IPC1-7):A61K39/39 主分类号 A61K39/00
代理机构 代理人
主权项
地址